Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Kimberly-Clark is reportedly close to selling its Kleenex and international tissue operations to Brazil’s Suzano for approximately $3.5 billion, according to sources cited by The Wall Street Journal. The deal, expected to finalize as soon as Thursday, marks a strategic move in Kimberly-Clark’s global restructuring efforts.
The divestiture excludes North American operations and focuses on the company’s tissue businesses in other regions. The unit, generating around $500 million in annual EBITDA, was put up for sale in 2023. Kimberly-Clark’s goal has been to streamline its global operations amid rising costs and shifting market conditions.
In April, Reuters reported that Suzano, Royal Golden Eagle (RGE), and Asia Pulp & Paper (APP) were the final contenders for the international tissue division, which had been valued near $4 billion. Suzano, a major pulp and paper producer, previously acquired Kimberly-Clark’s Brazilian tissue operations in 2022.
The latest sale aligns with Kimberly-Clark’s strategy to focus on core markets as inflation and trade tariffs—particularly those imposed during President Donald Trump’s administration—have pressured profit margins. The company revised its annual earnings outlook in April due to elevated raw material and production costs tied to the tariffs.
Neither Kimberly-Clark (NYSE:KMB) nor Suzano responded to immediate requests for comment.
This move could significantly boost Suzano’s global footprint, particularly in the consumer tissue segment, while helping Kimberly-Clark reallocate resources and strengthen its position in the North American market. As global competition in consumer goods intensifies, strategic portfolio realignments like this one are expected to continue.
This high-profile acquisition highlights ongoing consolidation trends in the pulp and paper industry, with leading firms seeking economies of scale and global market share.
